A carregar...
Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
BACKGROUND: Certolizumab pegol is used to treat ankylosing spondylitis, Crohn’s disease, psoriatic arthritis, and rheumatoid arthritis. Unlike other monoclonal antibodies such as infliximab and adalimumab, certolizumab does not contain an Fc fraction and hence does not induce complement activation....
Na minha lista:
| Publicado no: | Balkan Med J |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Galenos Publishing
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6158467/ https://ncbi.nlm.nih.gov/pubmed/29687787 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/balkanmedj.2017.1224 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|